FXH vs XLV

Key Takeaways

• First Trust Health Care AlphaDEX Fund (FXH) employs a rules-based AlphaDEX methodology to select and tier-weight health care stocks, while State Street Health Care Select Sector SPDR ETF (XLV) tracks a market-cap-weighted index of S&P 500 health care companies.
• FXH offers exposure to approximately 70–80 holdings with a focus on growth and value factors, resulting in a more equal-weighted approach compared to XLV’s roughly 60 holdings dominated by large-cap names.
• XLV maintains a significantly lower expense ratio of 0.08% versus FXH’s 0.61%, making it more cost-efficient for long-term buy-and-hold strategies within the health care sector.
• Both ETFs provide pure-play exposure to the U.S. health care sector, but FXH’s thematic tilt toward smaller or mid-cap opportunities within the sector introduces higher potential volatility relative to XLV’s broad-cap benchmark.
• Sector allocation for both centers on pharmaceuticals, health care equipment, providers, and biotechnology, with limited overlap in top holdings due to differing weighting schemes.
• Investors seeking lower costs and broad sector representation may favor XLV, while those targeting quantitative factor exposure may consider FXH despite the higher fee.

Introduction

Health care remains a defensive yet innovation-driven sector amid ongoing demographic shifts, regulatory changes, and technological advancements in pharmaceuticals and medical devices. First Trust Health Care AlphaDEX Fund (FXH) and State Street Health Care Select Sector SPDR ETF (XLV) both target U.S. health care equities but employ distinct methodologies. They do not compete directly as identical products; instead, they offer alternative exposure strategies within the same sector, allowing investors to choose between quantitative factor selection and traditional cap-weighted indexing based on risk tolerance and cost preferences.

First Trust Health Care AlphaDEX Fund (FXH) Overview

First Trust Health Care AlphaDEX Fund (FXH) seeks to track the StrataQuant Health Care AlphaDEX Index, a rules-based index that applies quantitative screens for growth and value factors to select stocks from the Russell 1000 Index within the health care sector. The fund holds approximately 70–80 securities, with top holdings including names such as Insmed, Regeneron Pharmaceuticals, and Incyte. Sector allocations concentrate in health technology and health services. FXH uses a modified equal-dollar weighting approach across tiers, distinguishing it as a rules-based, non-traditional passive strategy rather than pure market-cap replication. Its expense ratio stands at 0.61%.

State Street Health Care Select Sector SPDR ETF (XLV) Overview

State Street Health Care Select Sector SPDR ETF (XLV) aims to replicate the Health Care Select Sector Index, representing the health care component of the S&P 500. The fund holds roughly 60 securities and employs full replication with market-capitalization weighting. Prominent holdings typically include large-cap leaders such as Eli Lilly and other major pharmaceutical and device companies. Allocations span pharmaceuticals, health care equipment and supplies, providers and services, biotechnology, and life sciences tools. XLV operates as a traditional passive ETF with an expense ratio of 0.08%, offering broad, low-cost exposure to the sector’s largest constituents.

Industry and Thematic Backdrop

The U.S. health care sector continues to benefit from aging population trends, advances in biotechnology and personalized medicine, and steady demand for medical services. Macroeconomic factors including interest rate expectations and potential regulatory developments around drug pricing influence capital flows. Both ETFs remain sensitive to earnings cycles in pharmaceuticals and medical technology, with risks tied to policy changes and innovation timelines. Sector rotation toward defensive areas has supported health care allocations during periods of economic uncertainty in recent market cycles.

Performance and Positioning Comparison

In recent weeks and months, the two ETFs have exhibited differing sensitivities due to their construction. FXH’s factor-driven selection and tiered weighting can lead to greater dispersion in returns when mid-cap or growth-oriented health care names outperform. XLV’s cap-weighted structure aligns more closely with large-cap leaders, often resulting in lower volatility during sector rotations. Relative positioning favors XLV for investors prioritizing broad diversification and cost efficiency, while FXH may appeal during periods when quantitative signals favor specific health care sub-themes. Both have navigated earnings cycles and macroeconomic shifts with sector-specific drivers rather than isolated price movements.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your ETF and sector analysis.

Tickeron AI Verdict

Based on observable structural characteristics, Tickeron’s AI would currently assign a higher probability of preference to State Street Health Care Select Sector SPDR ETF (XLV). Its substantially lower expense ratio, broad diversification across leading health care names, and established passive replication methodology provide a more cost-efficient and stable positioning within the sector. FXH’s rules-based approach offers distinct factor exposure but carries a higher fee that may reduce net returns over extended holding periods unless specific quantitative signals demonstrate consistent outperformance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations